Patents by Inventor Martin L. Breitman

Martin L. Breitman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Receptor tyrosine kinase
    Patent number: 5998187
    Abstract: Novel receptor tyrosine kinase protein and isoforms thereof which are expressed in cells of the endothelial lineage, and DNA segments encoding the novel protein and isoforms thereof are disclosed. Methods for identifying ligands which are capable of binding to the receptor protein and methods for screening for agonist or antagonist substances of the interaction of the protein and a ligand are also disclosed.
    Type: Grant
    Filed: April 23, 1997
    Date of Patent: December 7, 1999
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Martin L. Breitman, Janet Rossant, Daniel J. Dumont, Terry P. Yamaguchi, Jo-Ann Breitman
  • Nucleic acid encoding tek receptor tyrosine kinase
    Patent number: 5681714
    Abstract: Novel receptor tyrosine kinase protein and isoforms thereof which are expressed in cells of the endothelial lineage, and DNA segments encoding the novel protein and isoforms thereof are disclosed. Methods for identifying ligands which are capable of binding to the receptor protein and methods for screening for agonist or antagonist substances of the interaction of the protein and a ligand are also disclosed.
    Type: Grant
    Filed: July 20, 1994
    Date of Patent: October 28, 1997
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Martin L. Breitman, deceased, Janet Rossant, Daniel J. Dumont, Terry P. Yamaguchi
  • Tissue specific transcriptional regulatory element
    Patent number: 5466596
    Abstract: A novel transcriptional regulatory element which is capable of directing expression of a gene specifically in cells of the endothelial lineage. The transcriptional regulatory element may be used to target expression of a gene in cells of the endothelial lineage.
    Type: Grant
    Filed: August 25, 1992
    Date of Patent: November 14, 1995
    Assignee: Mount Sinai Hospital Corporation
    Inventors: Martin L. Breitman, Daniel Dumont, Gerard G. Gradwohl